{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:57:46Z","timestamp":1793653066654,"version":"4.5.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Development Fund (FDCT) of Macao SAR","award":["FDCT\/0048\/2022\/A1"],"award-info":[{"award-number":["FDCT\/0048\/2022\/A1"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NSFC 81772980"],"award-info":[{"award-number":["NSFC 81772980"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Triple-negative breast cancer (TNBC) is characterized by aggressive clinical behaviour and frequent resistance to chemotherapy. While ferroptosis\u2014an iron-dependent form of cell death driven by lipid peroxidation\u2014holds promise as a therapeutic strategy, its efficacy is often limited by adaptive resistance mechanisms that remain incompletely understood. C-terminal binding protein (CtBP) is an oncogene associated with poor prognosis in TNBC; however, whether CtBP confers resistance to oxidative stress and ferroptosis, thereby contributing to its oncogenic function, remains unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We utilized both in vitro cell lines and in vivo mouse models to investigate the role of CtBP in regulating oxidative stress and ferroptosis sensitivity. Integrative analyses, including transcriptomics, metabolomics, and clinical data interrogation, were employed to elucidate the mechanisms underlying CtBP-mediated resistance. Key mechanistic findings were further validated in clinical TNBC specimens using protein correlation analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We identified CtBP as a stress-inducible gene that is essential for ferroptosis resistance in TNBC. Mechanistically, CtBP promotes resistance by transcriptionally upregulating Prolyl 4-Hydroxylase Subunit Beta (P4HB). P4HB, localized to the endoplasmic reticulum (ER), functions as a chaperone to facilitate the correct folding and membrane maturation of SLC7A11, the catalytic subunit of the system xc\n                      <jats:sup>-<\/jats:sup>\n                      \u2009\u2009cystine\/glutamate antiporter pivotal for glutathione (GSH) biosynthesis. We demonstrated that P4HB-mediated SLC7A11 maturation relies on its disulfide isomerase activity and ER retention signal (KDEL). Depletion of either CtBP or P4HB impaired SLC7A11 membrane trafficking, lead to accumulation of lipid peroxides and sensitization to ferroptosis. Conversely, P4HB overexpression restored SLC7A11 function and ferroptosis resistance in CtBP-deficient cells. Furthermore, significant positive correlations among CtBP, P4HB, and SLC7A11 expressions in clinical samples underscore the critical role of CtBP\/P4HB\/SLC7A11 axis in driving cancer aggressiveness. In vivo, targeting the CtBP\/P4HB\/SLC7A11 axis sensitized TNBC xenografts to the ferroptosis inducer RSL3, significantly suppressing tumor growth and lung metastasis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study identifies the CtBP\/P4HB\/SLC7A11 axis as a critical mediator of ferroptosis resistance in TNBC. These findings highlight this pathway as a potent therapeutic target to overcome resistance and enhance the efficacy of ferroptosis-inducing regimens in TNBC treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-026-03727-1","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:05:22Z","timestamp":1778915122000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CtBP promoted P4HB mediates SLC7A11 maturation to confer ferroptosis resistance in triple-negative breast cancer"],"prefix":"10.1186","volume":"45","author":[{"given":"Lifen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongliang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-jun","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"issue":"18","key":"3727_CR1","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1182\/blood-2011-10-385658","volume":"119","author":"M Nieborowska-Skorska","year":"2012","unstructured":"Nieborowska-Skorska M, et al. Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors. Blood. 2012;119(18):4253\u201363.","journal-title":"Blood"},{"key":"3727_CR2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.copbio.2021.03.001","volume":"68","author":"G Asantewaa","year":"2021","unstructured":"Asantewaa G, Harris IS. Glutathione and its precursors in cancer. Curr Opin Biotechnol. 2021;68:292\u20139.","journal-title":"Curr Opin Biotechnol"},{"issue":"4","key":"3727_CR3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei G, Zhuang L, Gan B. The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 2024;42(4):513\u201334.","journal-title":"Cancer Cell"},{"issue":"7","key":"3727_CR4","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.molcel.2023.03.005","volume":"83","author":"SJ Dixon","year":"2023","unstructured":"Dixon SJ, Pratt DA. Ferroptosis: a flexible constellation of related biochemical mechanisms. Mol Cell. 2023;83(7):1030\u201342.","journal-title":"Mol Cell"},{"key":"3727_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","volume":"133","author":"TM Seibt","year":"2019","unstructured":"Seibt TM, Proneth B, Conrad M. Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic Biol Med. 2019;133:144\u201352.","journal-title":"Free Radic Biol Med"},{"issue":"7784","key":"3727_CR6","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575(7784):688\u201392.","journal-title":"Nature"},{"issue":"7860","key":"3727_CR7","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593(7860):586\u201390.","journal-title":"Nature"},{"issue":"13","key":"3727_CR8","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","volume":"186","author":"D Liang","year":"2023","unstructured":"Liang D, et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell. 2023;186(13):2748-2764 e22.","journal-title":"Cell"},{"issue":"1","key":"3727_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41556-023-01314-6","volume":"26","author":"W Cui","year":"2024","unstructured":"Cui W, et al. Gut microbial metabolite facilitates colorectal cancer development via ferroptosis inhibition. Nat Cell Biol. 2024;26(1):124\u201337.","journal-title":"Nat Cell Biol"},{"issue":"8","key":"3727_CR10","doi-asserted-by":"publisher","first-page":"112945","DOI":"10.1016\/j.celrep.2023.112945","volume":"42","author":"Z Yang","year":"2023","unstructured":"Yang Z, et al. HIF-1alpha drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1. Cell Rep. 2023;42(8):112945.","journal-title":"Cell Rep"},{"issue":"9","key":"3727_CR11","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.biocel.2007.01.025","volume":"39","author":"G Chinnadurai","year":"2007","unstructured":"Chinnadurai G. Transcriptional regulation by C-terminal binding proteins. Int J Biochem Cell Biol. 2007;39(9):1593\u2013607.","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"3727_CR12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/15384047.2017.1323586","volume":"18","author":"MM Dcona","year":"2017","unstructured":"Dcona MM, et al. CtBP- an emerging oncogene and novel small molecule drug target: advances in the understanding of its oncogenic action and identification of therapeutic inhibitors. Cancer Biol Ther. 2017;18(6):379\u201391.","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"3727_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S1097-2765(02)00443-4","volume":"9","author":"G Chinnadurai","year":"2002","unstructured":"Chinnadurai G. CtBP, an unconventional transcriptional corepressor in development and oncogenesis. Mol Cell. 2002;9(2):213\u201324.","journal-title":"Mol Cell"},{"issue":"18","key":"3727_CR14","doi-asserted-by":"publisher","first-page":"10348","DOI":"10.1128\/JVI.00786-13","volume":"87","author":"MJ Cohen","year":"2013","unstructured":"Cohen MJ, et al. Dissection of the C-terminal region of E1A redefines the roles of CtBP and other cellular targets in oncogenic transformation. J Virol. 2013;87(18):10348\u201355.","journal-title":"J Virol"},{"issue":"10","key":"3727_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41389-019-0163-x","volume":"8","author":"AT Chawla","year":"2019","unstructured":"Chawla AT, et al. CtBP-a targetable dependency for tumor-initiating cell activity and metastasis in pancreatic adenocarcinoma. Oncogenesis. 2019;8(10):55.","journal-title":"Oncogenesis"},{"issue":"4","key":"3727_CR16","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/gutjnl-2015-310838","volume":"66","author":"O de Barrios","year":"2017","unstructured":"de Barrios O, et al. ZEB1-induced tumourigenesis requires senescence inhibition via activation of DKK1\/mutant p53\/Mdm2\/CtBP and repression of macroH2A1. Gut. 2017;66(4):666\u201382.","journal-title":"Gut"},{"issue":"12","key":"3727_CR17","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1038\/s41388-018-0570-z","volume":"38","author":"Z Zhao","year":"2019","unstructured":"Zhao Z, et al. CtBP promotes metastasis of breast cancer through repressing cholesterol and activating TGF-beta signaling. Oncogene. 2019;38(12):2076\u201391.","journal-title":"Oncogene"},{"issue":"1","key":"3727_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.molcel.2015.01.023","volume":"58","author":"K Ichikawa","year":"2015","unstructured":"Ichikawa K, et al. MCRIP1, an ERK substrate, mediates ERK-induced gene silencing during epithelial-mesenchymal transition by regulating the co-repressor CtBP. Mol Cell. 2015;58(1):35\u201346.","journal-title":"Mol Cell"},{"key":"3727_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-025-01554-0","author":"L Tai","year":"2025","unstructured":"Tai L, et al. Reciprocal stabilization of CtBP and TRIM28 represses autophagy to promote metastasis. Nat Struct Mol Biol. 2025. https:\/\/doi.org\/10.1038\/s41594-025-01554-0.","journal-title":"Nat Struct Mol Biol"},{"key":"3727_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aau9529","author":"CN Birts","year":"2020","unstructured":"Birts CN, et al. p53 is regulated by aerobic glycolysis in cancer cells by the CtBP family of NADH-dependent transcriptional regulators. Sci Signal. 2020. https:\/\/doi.org\/10.1126\/scisignal.aau9529.","journal-title":"Sci Signal"},{"issue":"7","key":"3727_CR21","first-page":"E819","volume":"112","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, et al. Retraction for Zhang et al., Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex. Proc Natl Acad Sci U S A. 2015;112(7):E819.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"3727_CR22","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/nn1791","volume":"9","author":"M Garriga-Canut","year":"2006","unstructured":"Garriga-Canut M, et al. 2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat Neurosci. 2006;9(11):1382\u20137.","journal-title":"Nat Neurosci"},{"issue":"1","key":"3727_CR23","doi-asserted-by":"publisher","first-page":"e1620","DOI":"10.1038\/cddis.2014.587","volume":"6","author":"L Wang","year":"2015","unstructured":"Wang L, et al. CtBP maintains cancer cell growth and metabolic homeostasis via regulating SIRT4. Cell Death Dis. 2015;6(1):e1620.","journal-title":"Cell Death Dis"},{"issue":"3","key":"3727_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41389-018-0036-8","volume":"7","author":"L Wang","year":"2018","unstructured":"Wang L, et al. Molecular link between glucose and glutamine consumption in cancer cells mediated by CtBP and SIRT4. Oncogenesis. 2018;7(3):26.","journal-title":"Oncogenesis"},{"issue":"13","key":"3727_CR25","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.7150\/thno.30814","volume":"9","author":"D Hao","year":"2019","unstructured":"Hao D, et al. Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome. Theranostics. 2019;9(13):3952\u201365.","journal-title":"Theranostics"},{"issue":"7","key":"3727_CR26","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.7150\/ijbs.80952","volume":"19","author":"J Li","year":"2023","unstructured":"Li J, et al. Metabolic modulation of CtBP dimeric status impacts the repression of DNA damage repair genes and the platinum sensitivity of ovarian cancer. Int J Biol Sci. 2023;19(7):2081\u201396.","journal-title":"Int J Biol Sci"},{"key":"3727_CR27","doi-asserted-by":"publisher","DOI":"10.1021\/cb500820b","author":"BJ Hilbert","year":"2015","unstructured":"Hilbert BJ, et al. Structure-guided design of a high affinity inhibitor to human CtBP. ACS Chem Biol. 2015. https:\/\/doi.org\/10.1021\/cb500820b.","journal-title":"ACS Chem Biol"},{"issue":"8","key":"3727_CR28","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1039\/c3sc50481f","volume":"4","author":"CN Birts","year":"2013","unstructured":"Birts CN, et al. A cyclic peptide inhibitor of C-terminal binding protein dimerization links metabolism with mitotic fidelity in breast cancer cells. Chem Sci. 2013;4(8):3046\u201357.","journal-title":"Chem Sci"},{"issue":"18","key":"3727_CR29","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.4161\/cc.9.18.12936","volume":"9","author":"MW Straza","year":"2010","unstructured":"Straza MW, et al. Therapeutic targeting of C-terminal binding protein in human cancer. Cell Cycle. 2010;9(18):3740\u201350.","journal-title":"Cell Cycle"},{"key":"3727_CR30","doi-asserted-by":"crossref","unstructured":"Blevins MA, et al. Small Molecule, NSC95397, Inhibits the CtBP1-Protein Partner Interaction and CtBP1-Mediated Transcriptional Repression. J Biomol Screen. 2014.","DOI":"10.1177\/1087057114561400"},{"issue":"1","key":"3727_CR31","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41467-017-00707-0","volume":"8","author":"Y Shen","year":"2017","unstructured":"Shen Y, et al. Bioenergetic state regulates innate inflammatory responses through the transcriptional co-repressor CtBP. Nat Commun. 2017;8(1):624.","journal-title":"Nat Commun"},{"issue":"5561","key":"3727_CR32","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1126\/science.1069300","volume":"295","author":"Q Zhang","year":"2002","unstructured":"Zhang Q, Piston DW, Goodman RH. Regulation of corepressor function by nuclear NADH. Science. 2002;295(5561):1895\u20137.","journal-title":"Science"},{"issue":"16","key":"3727_CR33","doi-asserted-by":"publisher","first-page":"9202","DOI":"10.1073\/pnas.1633591100","volume":"100","author":"CC Fjeld","year":"2003","unstructured":"Fjeld CC, Birdsong WT, Goodman RH. Differential binding of NAD+ and NADH allows the transcriptional corepressor carboxyl-terminal binding protein to serve as a metabolic sensor. Proc Natl Acad Sci U S A. 2003;100(16):9202\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"3727_CR34","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/nsmb.1941","volume":"17","author":"LJ Di","year":"2010","unstructured":"Di LJ, et al. Transcriptional regulation of BRCA1 expression by a metabolic switch. Nat Struct Mol Biol. 2010;17(12):1406\u201313.","journal-title":"Nat Struct Mol Biol"},{"key":"3727_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.587","volume":"6","author":"L Wang","year":"2015","unstructured":"Wang L, et al. CtBP maintains cancer cell growth and metabolic homeostasis via regulating SIRT4. Cell Death Dis. 2015;6:e1620.","journal-title":"Cell Death Dis"},{"issue":"2","key":"3727_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nchembio.1986","volume":"12","author":"MG Rees","year":"2016","unstructured":"Rees MG, et al. Correlating chemical sensitivity and basal gene expression reveals mechanism of action. Nat Chem Biol. 2016;12(2):109\u201316.","journal-title":"Nat Chem Biol"},{"issue":"D1","key":"3727_CR37","doi-asserted-by":"publisher","first-page":"D571","DOI":"10.1093\/nar\/gkac935","volume":"51","author":"N Zhou","year":"2023","unstructured":"Zhou N, et al. FerrDb V2: update of the manually curated database of ferroptosis regulators and ferroptosis-disease associations. Nucleic Acids Res. 2023;51(D1):D571\u201382.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"3727_CR38","doi-asserted-by":"publisher","first-page":"366","DOI":"10.21037\/tlcr-22-138","volume":"11","author":"CF Pan","year":"2022","unstructured":"Pan CF, et al. CircP4HB regulates ferroptosis via SLC7A11-mediated glutathione synthesis in lung adenocarcinoma. Transl Lung Cancer Res. 2022;11(3):366\u201380.","journal-title":"Transl Lung Cancer Res"},{"issue":"2","key":"3727_CR39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in cancer. Cancer Cell. 2020;38(2):167\u201397.","journal-title":"Cancer Cell"},{"issue":"1","key":"3727_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.molcel.2023.11.001","volume":"84","author":"F Hecht","year":"2024","unstructured":"Hecht F, et al. Regulation of antioxidants in cancer. Mol Cell. 2024;84(1):23\u201333.","journal-title":"Mol Cell"},{"issue":"10","key":"3727_CR41","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00109-021-02107-w","volume":"99","author":"Z Chen","year":"2021","unstructured":"Chen Z. The transrepression and transactivation roles of CtBPs in the pathogenesis of different diseases. J Mol Med (Berl). 2021;99(10):1335\u201347.","journal-title":"J Mol Med (Berl)"},{"issue":"5","key":"3727_CR42","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"8","key":"3727_CR43","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12(8):599\u2013620.","journal-title":"Protein Cell"},{"issue":"1","key":"3727_CR44","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41420-022-01212-0","volume":"8","author":"T Ma","year":"2022","unstructured":"Ma T, et al. GPX4-independent ferroptosis-a new strategy in disease\u2019s therapy. Cell Death Discov. 2022;8(1):434.","journal-title":"Cell Death Discov"},{"key":"3727_CR45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/bs.vh.2022.09.002","volume":"121","author":"DA Averill-Bates","year":"2023","unstructured":"Averill-Bates DA. The antioxidant glutathione. Vitam Horm. 2023;121:109\u201341.","journal-title":"Vitam Horm"},{"key":"3727_CR46","first-page":"47","volume":"7","author":"Y Wang","year":"2024","unstructured":"Wang Y, Yu G, Chen X. Mechanism of ferroptosis resistance in cancer cells. Cancer Drug Resist. 2024;7:47.","journal-title":"Cancer Drug Resist"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-026-03727-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03727-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03727-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T02:02:15Z","timestamp":1783562535000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-026-03727-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3727"],"URL":"https:\/\/doi.org\/10.1186\/s13046-026-03727-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8199205\/v1","asserted-by":"object"}]},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Animal Research Ethics Committee of The University of Macau. The approval number is UMARE-012\u20142020.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}